Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:10 am Purchase | 2021-12-31 | 13G | PROQR THERAPEUTICS N.V. PRQR | RTW INVESTMENTS LP | 7,027,725 9.900% | 1,939,232 (+38.11%) | Filing History |
| 2022-02-10 10:51 am Purchase | 2021-12-31 | 13G | PROQR THERAPEUTICS N.V. PRQR | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,715,152 6.630% | 165,090 (+3.63%) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | PROQR THERAPEUTICS N.V. PRQR | FMR LLC | 4,462,438 6.271% | 4,224,522 (+1775.64%) | Filing History |
| 2022-02-07 1:57 pm Purchase | 2021-12-31 | 13G | PROQR THERAPEUTICS N.V. PRQR | GOLDMAN SACHS GROUP INC GS | 3,973,650 5.600% | 467,286 (+13.33%) | Filing History |
| 2022-02-04 4:58 pm Purchase | 2021-12-31 | 13G | PROQR THERAPEUTICS N.V. PRQR | Stichting Aescap Life Sciences | 4,827,372 6.800% | 1,623,176 (+50.66%) | Filing History |
| 2022-02-04 09:12 am Purchase | 2021-12-31 | 13G | PROQR THERAPEUTICS N.V. PRQR | WELLINGTON MANAGEMENT GROUP LLP | 4,017,760 5.650% | 561,995 (+16.26%) | Filing History |
| 2021-09-10 1:03 pm Purchase | 2021-09-03 | 13G | PROQR THERAPEUTICS N.V. PRQR | ELI LILLY & Co LLY | 3,989,976 5.600% | 3,989,976 (New Position) | Filing History |